|
|
Office Locations:
|
2884 Sand Hill Road, Suite 121
Menlo Park, CA 94025
Phone: 650-388-3676
Fax: 650-388-3675
| |
|
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space. Members of the Lightstone team have worked together on numerous new life science enterprises over the last decade. Members of the Lightstone team manage a portfolio of more than 50 medical device and biotechnology companies across the ATV and Morgenthaler legacy funds (Legacy Funds). Lightstone invests in early stage therapeutics, with later stage investments pursued selectively. The firm pursues a balance between investing in breakthrough medical device and novel biopharmaceutical companies that have the potential to change medicine. The portfolio includes 20 IPOS and 19 acquisitions.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
